In this study, an integrated approach combining experimental validation with computational modeling is used to elucidate the molecular interactions between NAR, OLE, and miR-155-5p in prostate cancer cells, identify potential therapeutic targets, and characterize binding interactions. The gene discussed is CPSF4; the disease is prostate carcinoma.